Aarti Pharmalabs Limited (AARTIPHARM.NS)
INR 679.4
(8.81%)
INR 679.4
(8.81%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 23.93 INR | 12.08% |
| 2022 | 21.35 INR | 251276.47% |
| 2021 | -0.01 INR | 95.28% |
| 2020 | -0.18 INR | 76.0% |
| 2019 | -0.75 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 6.03 INR | -1.47% |
| 2024 Q1 | 6.12 INR | -15.0% |
| 2023 Q4 | 7.20 INR | 23.71% |
| 2023 FY | - INR | 12.08% |
| 2023 Q3 | 5.82 INR | 1.75% |
| 2023 Q2 | 5.72 INR | 10.0% |
| 2023 Q1 | 5.20 INR | 9.94% |
| 2022 Q3 | 5.26 INR | -6.74% |
| 2022 FY | - INR | 251276.47% |
| 2022 Q2 | 5.64 INR | -1.4% |
| 2022 Q4 | 4.73 INR | -10.08% |
| 2022 Q1 | 5.72 INR | 69.23% |
| 2021 Q4 | 3.38 INR | 0.0% |
| 2021 Q2 | -0.31 INR | 0.0% |
| 2021 Q3 | 3.38 INR | 1190.32% |
| 2021 FY | - INR | 95.28% |
| 2021 Q1 | -0.31 INR | 0.0% |
| 2020 FY | - INR | 76.0% |
| 2019 FY | - INR | 0.0% |